Pulmonary vascular diseases

Pulmonary vascular diseases such as pulmonary embolism and pulmonary hypertension contribute markedly to the global burden of chronic respiratory disease. Despite this, the burden of pulmonary vascular diseases remains underestimated, and the significance of pulmonary vascular disease merits greater attention from the medical community.

In recognition of this important disease area, this year’s virtual Congress programme will include a dedicated track including a variety of sessions and activities for health professionals involved in the treatment and management of pulmonary vascular diseases and for researchers who are interested in this disease area.

To view all sessions included in this specialist track, you need to access the online programme, click on 'Advanced' and select ‘Pulmonary vascular diseases’ from the ‘Diseases’ options. The programme can also be used to search for keywords, speakers and dates and to build your customised Congress agenda.

Hear from the ERS Pulmonary Vascular Diseases Assembly

We spoke to ERS officers who specialise in pulmonary vascular diseases to find out what you can expect from the virtual Congress and which programme highlights you should not miss. See what they told us:


Professor Anton Vonk Noordegraaf, ERS Pulmonary Vascular Diseases Assembly Secretary

Q: What can professionals specialising in pulmonary vascular diseases expect to gain from taking part in this year's Congress?

A: We have succeeded this year to present cutting edge scientific developments in the field of pulmonary hypertension, together with an educational programme that aims to update clinicians and expose them to clinical challenging cases.

Q: Is there a particular session in the pulmonary vascular diseases track that should not be missed?

A: It is difficult to choose. If I have to, I believe the session ‘Cardiovascular morbidity after acute pulmonary embolism’ (Tuesday 8 September, 18:00–19:00 CEST) is of high interest.

Q: What in your opinion will be the popular topics in the pulmonary vascular disease field during this year's Congress, and what will be particular highlight for you?

A: This year, the programme combines clinical challenging cases with recent developments in the field of pulmonary vascular science. A particular highlight is the session, ‘Don’t blame your parents: causes of pulmonary hypertension in early life’ (Tuesday 8 September, 15:4016:40 CEST), which will focus on recent gene discovery studies and pulmonary hypertension associated with early developmental lung disorders.

Dr Sheila Ramjug, ERS Pulmonary Vascular Diseases Assembly early career representative

Q: As an early-career professional with a focus on pulmonary vascular diseases, why is the upcoming Congress valuable to career development?

A: This year has been incredibly challenging for many of us working within the field of pulmonary medicine. The planned, innovative virtual ERS Congress of 2020 plans to address the topic of COVID-19, which has affected many of us.

In this pandemic much attention has been given to the topic of the prevention and management of venous thromboembolism in patients infected with the virus as well as its effects upon the pulmonary vascular system, and I look forward to these sessions especially, as we are uncertain of the long-term sequelae.

As an early-career professional, the ERS Congress keeps us abreast of the developments in the field of pulmonary vascular disease. Despite the condensed programme, the field of PVD has been well addressed to ensure continuing education of the early career member. I am thoroughly looking forward to the joint ERS/ESC session relating to the management of pulmonary hypertension (Monday 7 September, 11:5012:50 CEST) as well as the translational session on pulmonary hypertension  (Tuesday 8 September, 15:4016:40 CEST).

Assembly 13 welcomes you all too, on Sunday 6 September at 14:30 CEST for the Assembly members' meeting.

Learn more about the ERS Pulmonary Vascular Diseases Assembly

Back to 'Eight major respiratory topics'

View all programme highlights


Copyright © 2020 - ERS International Congress - European Respiratory Society. All Rights Reserved.